Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
26.11
+0.99 (3.94%)
Sep 2, 2026, 11:54 AM EDT - Market open
KMTS Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 |
Cash & Equivalents | 99.71 | 237.6 | 8.25 | 14.81 | 24.34 |
Short-Term Investments | 96.72 | - | - | - | - |
Cash & Short-Term Investments | 196.43 | 237.6 | 8.25 | 14.81 | 24.34 |
Cash Growth | -17.32% | 2780.29% | -44.30% | -39.16% | 322.90% |
Receivables | 14.54 | 8.08 | 2 | - | - |
Inventory | 6.71 | 6.57 | 3.29 | 2.11 | - |
Prepaid Expenses | 1.69 | 1.39 | 0.95 | 1.13 | 0.51 |
Other Current Assets | 2.98 | 1.69 | 0.42 | 0.37 | 1.35 |
Total Current Assets | 222.36 | 255.33 | 14.91 | 18.42 | 26.2 |
Property, Plant & Equipment | 62.45 | 36.91 | 28.39 | 16.72 | 3.08 |
Long-Term Investments | 70.77 | - | - | - | - |
Other Long-Term Assets | 2.89 | 3.51 | 2.65 | 3.51 | 1.24 |
Total Assets | 358.47 | 295.74 | 45.95 | 38.66 | 30.52 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 |
Accounts Payable | 27.3 | 23.96 | 23.89 | 6.16 | 1.7 |
Accrued Expenses | 23.05 | 13.83 | 9.08 | 8.77 | 3.81 |
Current Portion of Long-Term Debt | - | - | - | 20.45 | - |
Current Portion of Leases | 0.03 | 0.19 | - | 1.37 | 1.06 |
Current Income Taxes Payable | - | - | - | - | 0.04 |
Total Current Liabilities | 50.37 | 37.98 | 32.97 | 36.74 | 6.61 |
Long-Term Debt | 42.65 | 41.1 | 42.54 | 17.32 | 20.24 |
Long-Term Leases | 4.11 | 3.03 | 2.63 | - | 1.55 |
Other Long-Term Liabilities | 1.68 | 8.24 | 0.08 | 0.06 | 0.36 |
Total Liabilities | 98.81 | 90.34 | 78.22 | 54.12 | 28.76 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 |
Common Stock | 58.38 | 51.35 | 19.91 | 0 | 0 |
Additional Paid-In Capital | 853.35 | 674.31 | 177.15 | 194.74 | 171.85 |
Retained Earnings | -651.86 | -520.25 | -406.44 | -312.32 | -170.08 |
Comprehensive Income & Other | -0.22 | - | - | - | - |
Total Common Equity | 259.66 | 205.41 | -209.38 | -117.58 | 1.77 |
Shareholders' Equity | 259.66 | 205.41 | -32.27 | -15.47 | 1.77 |
Total Liabilities & Equity | 358.47 | 295.74 | 45.95 | 38.66 | 30.52 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Apr '25 Apr 30, 2025 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '21 Apr 30, 2021 |
Total Debt | 46.79 | 44.31 | 45.17 | 39.13 | 22.85 |
Net Cash (Debt) | 149.64 | 193.28 | -36.92 | -24.32 | 1.49 |
Net Cash Growth | -22.58% | - | - | - | -71.85% |
Net Cash Per Share | 2.76 | 7.86 | -1.86 | -229.89 | 14.11 |
Filing Date Shares Outstanding | 58.6 | 51.35 | 0.11 | 0.11 | 0.11 |
Total Common Shares Outstanding | 58.38 | 51.35 | 0.11 | 0.11 | 0.11 |
Working Capital | 171.99 | 217.35 | -18.06 | -18.32 | 19.59 |
Book Value Per Share | 4.45 | 4.00 | -1978.84 | -1111.24 | 16.69 |
Tangible Book Value | 259.66 | 205.41 | -209.38 | -117.58 | 1.77 |
Tangible Book Value Per Share | 4.45 | 4.00 | -1978.84 | -1111.24 | 16.69 |
Machinery | 88.06 | 57.23 | 39.66 | 20.26 | 0.87 |
Construction In Progress | 1.54 | 0.64 | 1.66 | - | - |
Leasehold Improvements | 0.92 | 0.92 | 0.89 | 0.87 | 0.41 |